| |
| |
|
| Insider
Information: |
Root Jonathan D |
| Relationship: |
10% Owner |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
652,550 |
|
|
Indirect Shares
|
141,997 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$311,843 |
|
|
| Total
Shares |
794,547 |
|
|
| Total
Value |
$311,843 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -125.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Occam Networks Inc |
OCNW |
10% Owner |
2007-02-23 |
538 |
2007-02-23 |
0 |
Premium* |
|
|
Maxlinear Inc |
MXL |
10% Owner |
2011-02-15 |
0 |
2011-02-15 |
2,220 |
Premium* |
|
|
Atricure, Inc. |
ATRC |
10% Owner |
2012-06-06 |
0 |
2012-06-13 |
11,873 |
Premium* |
|
|
Inari Medical, Inc. |
NARI |
Director |
2024-04-24 |
541,149 |
2024-04-24 |
335 |
Premium* |
|
|
Silverback Therapeutics, Inc. |
SBTX |
Director |
2021-12-13 |
95,238 |
2021-12-13 |
0 |
Premium* |
|
|
Edgewise Therapeutics, Inc. |
EWTX |
Director |
2022-02-25 |
15,625 |
2022-02-25 |
0 |
Premium* |
|
|
Effector Therapeutics Ord Shs |
EFTR |
10% Owner |
2021-08-25 |
0 |
2022-08-03 |
127,569 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRC |
Atricure, Inc. |
10% Owner |
– – • |
2012-06-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(352,579) |
14,452 |
0 |
- |
|
| ATRC |
Atricure, Inc. |
10% Owner |
– – • |
2012-06-07 |
4 |
S |
$9.44 |
$47,579 |
I/I |
(5,038) |
9,858 |
0 |
- |
|
| ATRC |
Atricure, Inc. |
10% Owner |
– – • |
2012-06-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(352,579) |
11,873 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Director |
– • – |
2021-03-30 |
4 |
B |
$16.00 |
$250,000 |
D/D |
15,625 |
15,625 |
2.39 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Director |
– • – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
I/I |
3,473,543 |
3,473,543 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Director |
– • – |
2022-02-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,473,543) |
0 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-08-25 |
4 |
A |
$0.00 |
$7,127,850 |
I/I |
4,822,114 |
149,486 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-09 |
4 |
S |
$11.00 |
$316,750 |
I/I |
(28,785) |
148,593 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-10 |
4 |
S |
$10.44 |
$354,824 |
I/I |
(34,000) |
147,539 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-11 |
4 |
S |
$10.37 |
$124,592 |
I/I |
(12,017) |
147,166 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-12 |
4 |
S |
$10.07 |
$120,840 |
I/I |
(12,000) |
146,794 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-15 |
4 |
S |
$9.81 |
$49,751 |
I/I |
(5,071) |
146,637 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-16 |
4 |
S |
$9.42 |
$78,357 |
I/I |
(8,319) |
146,380 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-17 |
4 |
S |
$9.13 |
$93,415 |
I/I |
(10,235) |
146,063 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-18 |
4 |
S |
$8.53 |
$142,801 |
I/I |
(16,745) |
145,544 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-19 |
4 |
S |
$8.12 |
$58,804 |
I/I |
(7,241) |
145,320 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-22 |
4 |
S |
$7.86 |
$205,798 |
I/I |
(26,183) |
144,508 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-23 |
4 |
S |
$7.40 |
$110,150 |
I/I |
(14,879) |
144,047 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-24 |
4 |
S |
$7.36 |
$268,605 |
I/I |
(36,520) |
142,915 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-26 |
4 |
S |
$7.01 |
$35,242 |
I/I |
(5,026) |
142,759 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-29 |
4 |
S |
$6.70 |
$172,490 |
I/I |
(25,764) |
141,960 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-11-30 |
4 |
S |
$6.53 |
$179,036 |
I/I |
(27,409) |
141,110 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-12-01 |
4 |
S |
$6.44 |
$123,880 |
I/I |
(19,245) |
140,513 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-12-02 |
4 |
S |
$5.68 |
$46,082 |
I/I |
(8,113) |
140,261 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-05-09 |
4 |
S |
$2.54 |
$10,144 |
I/I |
(4,000) |
140,137 |
0 |
- |
|
74 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
